145 related articles for article (PubMed ID: 35244929)
21. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer in women aging 35 years old and younger: The Egyptian National Cancer Institute (NCI) experience.
Darwish AD; Helal AM; Aly El-Din NH; Solaiman LL; Amin A
Breast; 2017 Feb; 31():1-8. PubMed ID: 27771499
[TBL] [Abstract][Full Text] [Related]
23. Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Chakraborty A; Bose CK; Basak J; Sen AN; Mishra R; Mukhopadhyay A
Indian J Med Res; 2016 May; 143(Supplement):S45-S51. PubMed ID: 27748277
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer in young women from a low risk population in Nepal.
Thapa B; Singh Y; Sayami P; Shrestha UK; Sapkota R; Sayami G
Asian Pac J Cancer Prev; 2013; 14(9):5095-9. PubMed ID: 24175782
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer in woman younger than 35 years in Tunisia: retrospective study about 124 cases].
Bouzid N; Lahmar R; Tebra S; Bouaouina N
Gynecol Obstet Fertil; 2013 Jun; 41(6):356-60. PubMed ID: 23747138
[TBL] [Abstract][Full Text] [Related]
26. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.
Ugras S; Stempel M; Patil S; Morrow M
Ann Surg Oncol; 2014 Nov; 21(12):3780-6. PubMed ID: 24952028
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
29. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
Mohapatra M; Sarma YS
J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
[TBL] [Abstract][Full Text] [Related]
31. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
Wo JY; Taghian AG; Nguyen PL; Raad RA; Sreedhara M; Bellon JR; Wong JS; Gadd MA; Smith BL; Harris JR
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):188-96. PubMed ID: 20171798
[TBL] [Abstract][Full Text] [Related]
32. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.
Bennis S; Abbass F; Akasbi Y; Znati K; Joutei KA; El Mesbahi O; Amarti A
BMC Res Notes; 2012 Aug; 5():436. PubMed ID: 22889054
[TBL] [Abstract][Full Text] [Related]
34. [Breast cancer in Tunisia: clinical and epidemiological study].
Maalej M; Frikha H; Ben Salem S; Daoud J; Bouaouina N; Ben Abdallah M; Ben Romdhane K
Bull Cancer; 1999 Mar; 86(3):302-6. PubMed ID: 10210765
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiological and anatomopathological profile of breast cancer at the Ibn Rochd University Hospital, Casablanca].
Fouhi ME; Benider A; Gaëtan KZA; Mesfioui A
Pan Afr Med J; 2020; 37():41. PubMed ID: 33209168
[TBL] [Abstract][Full Text] [Related]
36. Outcomes in patients with small node-negative invasive breast cancer.
Bao J; Donovan C; Amersi F; Zhang X; Giuliano AE; Chung A
Breast J; 2019 Jul; 25(4):638-643. PubMed ID: 31079425
[TBL] [Abstract][Full Text] [Related]
37. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
Braunstein LZ; Taghian AG; Niemierko A; Salama L; Capuco A; Bellon JR; Wong JS; Punglia RS; MacDonald SM; Harris JR
Breast Cancer Res Treat; 2017 Jan; 161(1):173-179. PubMed ID: 27807809
[TBL] [Abstract][Full Text] [Related]
38. [Pure colloid carcinoma of the breast: anatomoclinical study of seven cases].
Chtourou I; Makni SK; Bahri I; Abbes K; Sellami A; Fakhfakh I; Gouiaa N; Ayadi L; Frikha M; Daoud J; Boudawara TS
Cancer Radiother; 2009 Jan; 13(1):37-41. PubMed ID: 18703371
[TBL] [Abstract][Full Text] [Related]
39. Luminal B, Human Epidermal Growth Factor Receptor 2 (HER2/neu), and Triple-Negative Breast Cancers Associated With a Better Chemotherapy Response Than Luminal A Breast Cancers in Postneoadjuvant Settings.
Hashmi AA; Bukhari U; Najam J; Dowlah T; Ali AH; Diwan MA; Anjali F; Sham S; Zia S; Irfan M
Cureus; 2023 Jun; 15(6):e40066. PubMed ID: 37425505
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
